ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

doi:10.1111/pedi.13421

Review

. 2022 Dec;23(8):1406-1431.

doi: 10.1111/pedi.13421. Epub 2022 Dec 5.

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Affiliations

¹ Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
³ Pediatrics Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Andalusia, Spain.
⁴ Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
⁵ AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
⁶ Department of Woman and Child's Health, University of Padova, Padova, Italy.
⁷ Department of Pediatrics, Life Groenkloof Hospital, Pretoria, South Africa.
⁸ Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
⁹ Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
¹⁰ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

PMID: 36468192
DOI: 10.1111/pedi.13421

Review

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Jennifer L Sherr et al. Pediatr Diabetes. 2022 Dec.

. 2022 Dec;23(8):1406-1431.

doi: 10.1111/pedi.13421. Epub 2022 Dec 5.

Affiliations

¹ Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
³ Pediatrics Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Andalusia, Spain.
⁴ Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
⁵ AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
⁶ Department of Woman and Child's Health, University of Padova, Padova, Italy.
⁷ Department of Pediatrics, Life Groenkloof Hospital, Pretoria, South Africa.
⁸ Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
⁹ Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
¹⁰ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

PMID: 36468192
DOI: 10.1111/pedi.13421

No abstract available

Keywords: automated insulin delivery; connected pens; diabetes technology; insulin pumps.

PubMed Disclaimer

Cited by

Use of diabetes technology in children.
Schoelwer MJ, DeBoer MD, Breton MD. Schoelwer MJ, et al. Diabetologia. 2024 Oct;67(10):2075-2084. doi: 10.1007/s00125-024-06218-0. Epub 2024 Jul 12. Diabetologia. 2024. PMID: 38995398 Free PMC article. Review.
How to Safely Use Diluted Insulin in an Automated Insulin Delivery System in Very Young Children: An Educator Perspective.
Nicol E, Ashford J, Prampolini B, Marcovecchio ML. Nicol E, et al. J Diabetes Sci Technol. 2025 Mar 18:19322968251322183. doi: 10.1177/19322968251322183. Online ahead of print. J Diabetes Sci Technol. 2025. PMID: 40099422 Free PMC article.
Parental perspectives following the implementation of advanced hybrid closed-loop therapy in children and adolescents with type 1 diabetes and elevated glycaemia.
Lai ST, Styles SE, Boucsein A, Zhou Y, Michaels V, Jefferies C, Wilshire E, De Bock MI, Wheeler BJ. Lai ST, et al. Diabet Med. 2025 Mar;42(3):e15448. doi: 10.1111/dme.15448. Epub 2024 Nov 25. Diabet Med. 2025. PMID: 39587412 Free PMC article. Clinical Trial.
The Reporting Quality of Machine Learning Studies on Pediatric Diabetes Mellitus: Systematic Review.
Zrubka Z, Kertész G, Gulácsi L, Czere J, Hölgyesi Á, Nezhad HM, Mosavi A, Kovács L, Butte AJ, Péntek M. Zrubka Z, et al. J Med Internet Res. 2024 Jan 19;26:e47430. doi: 10.2196/47430. J Med Internet Res. 2024. PMID: 38241075 Free PMC article.
Glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system 2-year prospective, observational, two-center study.
Seget S, Chobot A, Tarasiewicz M, Bielawska A, Rusak E, Ochab A, Polanska J, Jarosz-Chobot P. Seget S, et al. Front Endocrinol (Lausanne). 2024 Feb 8;15:1332418. doi: 10.3389/fendo.2024.1332418. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38390211 Free PMC article.

See all "Cited by" articles

References

REFERENCES

1. Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines. Diabetes Care. 2013;36(7):2035-2037. doi:10.2337/dc12-1959
1. McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050. doi:10.1111/dme.12676
1. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384
1. Anderzen J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-a quality registry study. Pediatr Diabetes. 2020;21(4):621-627. doi:10.1111/pedi.13014
1. Hermann JM, Miller KM, Hofer SE, et al. The transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D exchange registry and those included in the German/Austrian DPV registry. Diabet Med. 2020;37(5):848-855. doi:10.1111/dme.14148

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

[1] Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines. Diabetes Care. 2013;36(7):2035-2037. doi:10.2337/dc12-1959

[2] Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines. Diabetes Care. 2013;36(7):2035-2037. doi:10.2337/dc12-1959

[3] McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050. doi:10.1111/dme.12676

[4] McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050. doi:10.1111/dme.12676

[5] Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384

[6] Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384

[7] Anderzen J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-a quality registry study. Pediatr Diabetes. 2020;21(4):621-627. doi:10.1111/pedi.13014

[8] Anderzen J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-a quality registry study. Pediatr Diabetes. 2020;21(4):621-627. doi:10.1111/pedi.13014

[9] Hermann JM, Miller KM, Hofer SE, et al. The transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D exchange registry and those included in the German/Austrian DPV registry. Diabet Med. 2020;37(5):848-855. doi:10.1111/dme.14148

[10] Hermann JM, Miller KM, Hofer SE, et al. The transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D exchange registry and those included in the German/Austrian DPV registry. Diabet Med. 2020;37(5):848-855. doi:10.1111/dme.14148

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Affiliations

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Authors

Affiliations

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical